A 60-year-old man with CHA2DS2-VASc 2 (HTN, age 60) declines anticoagulation and asks about aspirin instead. Best evidence-based counsel?...

Question

A 60-year-old man with CHA2DS2-VASc 2 (HTN, age 60) declines anticoagulation and asks about aspirin instead. Best evidence-based counsel?

Accepted Answer

Aspirin is not recommended as an alternative to OAC for stroke prevention in AF

Answer

Aspirin is an acceptable alternative to anticoagulation

Answer

Aspirin reduces stroke risk similarly to DOACs

Answer

Dual antiplatelet therapy equals OAC

Answer

No therapy is needed at CHA2DS2-VASc 2

us-abim MCQ (SBA): AF Antithrombotic Choice